Cargando…
Myasthenia Gravis: A Review of Available Treatment Approaches
Patients with autoimmune myasthenia gravis (MG) should be further classified before initiating therapy, as treatment response varies for ocular versus generalised, early onset versus late onset, and acetylcholine receptor antibody positive versus MuSK antibody positive disease. Most patients need im...
Autores principales: | Gilhus, Nils Erik, Owe, Jone F., Hoff, Jana Midelfart, Romi, Fredrik, Skeie, Geir Olve, Aarli, Johan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189457/ https://www.ncbi.nlm.nih.gov/pubmed/22007295 http://dx.doi.org/10.4061/2011/847393 |
Ejemplares similares
-
Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Complicating autoimmune diseases in myasthenia gravis: a review
por: Nacu, Aliona, et al.
Publicado: (2015) -
Maternal myasthenia gravis: a cause for arthrogryposis multiplex congenita
por: Midelfart Hoff, Jana, et al.
Publicado: (2015) -
Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls
por: Luckman, Steven P., et al.
Publicado: (2011)